======= PNPLA8 ======= == Gene Information == * **Official Symbol**: PNPLA8 * **Official Name**: patatin like phospholipase domain containing 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=50640|50640]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NP80|Q9NP80]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PNPLA8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PNPLA8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612123|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the patatin-like phospholipase domain containing protein family. Members of this family are phospholipases which catalyze the cleavage of fatty acids from membrane phospholipids. The product of this gene is a calcium-independent phospholipase. Mutations in this gene have been associated with mitochondrial myopathy with lactic acidosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2015]. * **UniProt Summary**: N/A |Patatin| |phosphatidylethanolamine catabolic process| |phosphatidylcholine catabolic process| |calcium-independent phospholipase A2 activity| |linoleic acid metabolic process| |prostanoid biosynthetic process| |prostaglandin biosynthetic process| |glycerophospholipid catabolic process| |lysophospholipase activity| |phosphatidylethanolamine metabolic process| |arachidonate transport| |arachidonic acid secretion| |phosphatidylethanolamine acyl-chain remodeling| |phosphatidylcholine acyl-chain remodeling| |icosanoid secretion| |icosanoid transport| |fatty acid derivative transport| |prostanoid metabolic process| |prostaglandin metabolic process| |phospholipid catabolic process| |unsaturated fatty acid biosynthetic process| |icosanoid biosynthetic process| |glycerolipid catabolic process| |peroxisomal membrane| |arachidonic acid metabolic process| |long-chain fatty acid transport| |fatty acid transport| |phosphatidylcholine metabolic process| |acid secretion| |fatty acid derivative biosynthetic process| |unsaturated fatty acid metabolic process| |peroxisome| |icosanoid metabolic process| |long-chain fatty acid metabolic process| |fatty acid biosynthetic process| |organophosphate catabolic process| |monocarboxylic acid transport| |fatty acid derivative metabolic process| |monocarboxylic acid biosynthetic process| |ammonium ion metabolic process| |cellular lipid catabolic process| |carboxylic acid transport| |organic acid transport| |lipid transport| |lipid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |glycerophospholipid metabolic process| |lipid localization| |fatty acid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |organic anion transport| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |anion transport| |small molecule biosynthetic process| |Golgi membrane| |perinuclear region of cytoplasm| |organophosphate metabolic process| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |cell death| |secretion| |lipid metabolic process| |ion transport| |ATP binding| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.83| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|1.98| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.98| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.04| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|2.08| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.22| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|2.23| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|2.27| |[[:results:exp16|DABN 2μM R00 exp16]]|2.3| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.46| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.52| ^Gene^Correlation^ |[[:human genes:t:timm23|TIMM23]]|0.427| |[[:human genes:m:mtx2|MTX2]]|0.423| |[[:human genes:g:gng11|GNG11]]|0.41| |[[:human genes:k:kcmf1|KCMF1]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 778 * **Expression level (log2 read counts)**: 4.65 {{:chemogenomics:nalm6 dist.png?nolink |}}